Variation in Clinical Practice of Intravenous Thrombolysis in Stroke in the Netherlands

被引：14

作者：

Bauer, Auke ^{[1
]}

Linnburg, Martien ^{[2
]}

Visser, Marieke Christine ^{[1
]}

机构：

[1] Vrije Univ Amsterdam Med Ctr, Dept Neurol, Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands

[2] Flevo Ziekenhuis, Dept Neurol, Almere, Netherlands

来源：

CEREBROVASCULAR DISEASES EXTRA | 2013年 / 3卷 / 01期

关键词：

Acute stroke; Thrombolysis; Quality of care;

D O I：

10.1159/000350707

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

In the Netherlands in 2010, 11% of patients with ischemic stroke received intravenous thrombolysis (IVT), varying from 4 to 26% between hospitals. The aim of this study was to investigate variation in clinical practice and organization of IVT in relationship to performance and outcome. In all 84 Dutch hospitals performing IVT, a stroke neurologist was approached using a web-based survey. The response rate was 82%. The study showed considerable variation. For example, door-to-needle time ranged from 25 to 80 min. High blood pressure was actively lowered before performing IVT by 57% of neurologists, while 35% chose to wait. 28% started IVT without knowledge of laboratory results. Better follow-up data are needed to see whether this variation results in differences in outcome. Copyright (C) 2013 S. Karger AG, Basel.

引用

页码：74 / 77

页数：4

共 8 条

[1]

[Anonymous], 2011, REPORT ACCESSIBILITY

[2] Off-Label Thrombolysis for Acute Ischemic Stroke: Rate, Clinical Outcome and Safety Are Influenced by the Definition of 'Minor Stroke' [J].

Breuer, L. ;

Blinzler, C. ;

Huttner, H. B. ;

Kiphuth, I. C. ;

Schwab, S. ;

Koehrmann, M. .

CEREBROVASCULAR DISEASES, 2011, 32 (02) :177-185

[3] Treatment Variations in Cerebral Venous Thrombosis: An International Survey [J].

Coutinho, J. M. ;

Seelig, R. ;

Bousser, M. -G. ;

Canhao, P. ;

Ferro, J. M. ;

Stam, J. .

CEREBROVASCULAR DISEASES, 2011, 32 (03) :298-300

[4]

Dutch national guidelines for stroke 2008, 2008, DUTCH SOC NEUR

[5]

Kjellstrom T, 2007, CEREBROVASC DIS, V23, P231

[6]

Limburg M, 2010, MEDISCH CONTACT, V65, P404

[7] The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial [J].

Sandercock, Peter ;

Wardlaw, Joanna M. ;

Lindley, Richard I. ;

Dennis, Martin ;

Cohen, Geoff ;

Murray, Gordon ;

Innes, Karen ;

Venables, Graham ;

Czlonkowska, Anna ;

Kobayashi, Adam ;

Ricci, Stefano ;

Murray, Veronica ;

Berge, Eivind ;

Slot, Karsten Bruins ;

Hankey, Graeme J. ;

Correia, Manuel ;

Peeters, Andre ;

Matz, Karl ;

Lyrer, Phillippe ;

Gubitz, Gord ;

Phillips, Stephen J. ;

Arauz, Antonio ;

Baigent, Colin ;

Chadwick, David ;

Tyrrell, Pippa ;

Lowe, Gordon ;

Farrall, Andrew ;

von Kummer, Rudiger ;

Cala, Lesley ;

von Heijne, Anders ;

Morris, Zoe ;

Adami, Alessandro ;

Potter, Gillian ;

Brady, Nick ;

Collins, Rory ;

Bath, Philip ;

van Gijn, Jan ;

Gray, Richard ;

Hart, Robert ;

Yusuf, Salim ;

Muir, Keith ;

Brainin, Michael ;

Engelter, Stefan ;

Terent, Andreas ;

Norrving, Bo ;

Wester, Per ;

Clark, Alison ;

Perry, David ;

Soosay, Vera ;

Buchanan, David .

LANCET, 2012, 379 (9834) :2352-2363

[8] Time Trends in Systemic Thrombolysis in a Large Hospital-Based Stroke Registry [J].

Singer, O. C. ;

Hamann, G. F. ;

Misselwitz, B. ;

Steinmetz, H. ;

Foerch, C. .

CEREBROVASCULAR DISEASES, 2012, 33 (04) :316-321

← 1 →